Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment

被引:0
|
作者
Xuefei Li
Yi Wang
Ziqiang Chen
Ming Ruan
Can Yang
Maolin Zhou
Ning Li
Lianping Xing
Hao Xu
Ling Yang
Qi Shi
Yongjun Wang
Jinman Chen
Qianqian Liang
机构
[1] Longhua Hospital,Key Laboratory of Theory and Therapy of Muscles and Bones
[2] Shanghai University of Traditional Chinese Medicine,Cardiovascular Department
[3] Spine Institute,Center for Systems Pharmacokinetics
[4] Shanghai University of Traditional Chinese Medicine,Center for Musculoskeletal Research
[5] Ministry of Education (Shanghai University of Traditional Chinese Medicine),Department of Pathology & Laboratory Medicine
[6] Longhua Hospital,undefined
[7] Shanghai University of Traditional Chinese Medicine,undefined
[8] Shanghai University of Traditional Chinese Medicine,undefined
[9] University of Rochester Medical Center,undefined
[10] University of Rochester Medical Center,undefined
关键词
Rheumatoid arthritis; Tumor necrosis factor transgenic mouse (TNF-Tg); Liver and kidney complications; Anti-TNF therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Hepatorenal pathologies in TNF-transgenic mouse model of rheumatoid arthritis are alleviated by anti-TNF treatment
    Li, Xuefei
    Wang, Yi
    Chen, Ziqiang
    Ruan, Ming
    Yang, Can
    Zhou, Maolin
    Li, Ning
    Xing, Lianping
    Xu, Hao
    Yang, Ling
    Shi, Qi
    Wang, Yongjun
    Chen, Jinman
    Liang, Qianqian
    ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [2] TNF-α Blockade Incompletely Reverses Inflammatory Pulmonary Pathology in the TNF-Transgenic Mouse Model of Rheumatoid Arthritis
    Wu, Emily
    Bell, Richard
    Schwarz, Edward
    Rahimi, Homaira
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [3] Anti-TNF Treatment in Rheumatoid Arthritis
    Geiler, Janina
    Buch, Maya
    McDermott, Michael F.
    CURRENT PHARMACEUTICAL DESIGN, 2011, 17 (29) : 3141 - 3154
  • [4] Rheumatoid Arthritis - Anti-TNF
    Chaabo, Khaldoun
    Kirkham, Bruce
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 27 (02) : 180 - 184
  • [5] Monocytes Membrane TNF Expression and Anti-TNF Treatment in Rheumatoid Arthritis
    Paoletti, Audrey
    Rohmer, Julien
    Pascaud, Juliette
    Oumouly, Bineta
    Riviere, Elodie
    Bitoun, Samuel
    Nocturne, Gaetane
    Mariette, Xavier
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [6] Predictors of neutropaenia on anti-TNF treatment for rheumatoid arthritis
    Rajakulendran, S.
    Gadsby, K.
    Allen, D.
    O'Reilly, S.
    Deighton, C.
    RHEUMATOLOGY, 2006, 45 : I48 - I49
  • [7] Pharmacogenetics of anti-TNF treatment in patients with rheumatoid arthritis
    Coenen, Marieke J. H.
    Toonen, Erik J. M.
    Scheffer, Hans
    Radstake, Timothy R. D. J.
    Barrera, Pilar
    Franke, Barbara
    PHARMACOGENOMICS, 2007, 8 (07) : 761 - 773
  • [8] Anti-TNF agents for rheumatoid arthritis
    Seymour, HE
    Worsley, A
    Smith, JM
    Thomas, SHL
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (03) : 201 - 208
  • [9] Anti-TNF therapy in rheumatoid arthritis
    Meyer, O
    PRESSE MEDICALE, 2000, 29 (09): : 463 - 468
  • [10] Anti-TNF in rheumatoid arthritis: an overview
    Radner, Helga
    Aletaha, Daniel
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2015, 165 (1-2) : 3 - 9